(Q43679054)

25 November 2017

title

Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors (English)

1 reference

25 November 2017

N M Lakkis

1

1 reference

25 November 2017

S George

2

1 reference

25 November 2017

E Thomas

3

1 reference

25 November 2017

M Ali

4

1 reference

25 November 2017

K Guyer

5

1 reference

25 November 2017

D Carville

6

1 reference

25 November 2017

publication date

1 July 2001

1 reference

Catheterization and Cardiovascular Interventions

25 November 2017

published in

1 reference

25 November 2017

volume

53

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

346-351

1 reference

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

25 November 2017

cites work

1 reference

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

Rapid platelet-function assay: an automated and quantitative cartridge-based method

21 January 2018

1 reference

Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

21 January 2018

1 reference

A critical reappraisal of the bleeding time

21 January 2018

1 reference

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

21 January 2018

1 reference

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

21 January 2018

1 reference

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors

21 January 2018

1 reference

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy

21 January 2018

1 reference

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CCD.1179

1 reference

25 November 2017

1 reference